Norway· NO-ID_C8190C4E-8044-499A-859B-354B916C057F
Optison
A perflutren, humanalbumin-mikrosphären product containing perflutren, registered in Norway by GE Healthcare AS. The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Perflutren, humanalbumin-mikrosphären is registered in 9 of 19 countries.
Countries holding a registration under ATC V08DA01 (perflutren, humanalbumin-mikrosphären), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Perflutren, humanalbumin-mikrosphären · ATC V08DA01
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
FEST (Norway)- Active substance
- Perflutren
- Manufacturer
- GE Healthcare AS
- Country
- Norway (NO)
- ATC code
- V08DA01
- ATC class
- Perflutren, Humanalbumin-Mikrosphären
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_C8190C4E-8044-499A-859B-354B916C057F
- no_varenummer0105295 x 3NOK 4546.8
- gtin7046260105294
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
159 interactions on record for perflutren, humanalbumin-mikrosphären.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Perflutren, humanalbumin-mikrosphären · interactions on record
159 records
- 36 severe
- 121 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Perflutren, humanalbumin-mikrosphären in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOptison 0.19 mg/mlGE Healthcare
- IcelandOptisonGE Healthcare AS
- NetherlandsOptison 0,19 mg/ml dispersie voor injectieGE Healthcare AS
- CzechiaLUMINITYLantheus EU Limited, Shannon
- SpainLUMINITY 150 MICROLITROS/ML GAS Y DISOLVENTE PARA SOLUCIÓN PARA DISPERSIÓN INYECTABLE Y PARA PERFUSIÓNLantheus Eu Limited
- SwedenLuminity 150 mikroliter/ml Injektions-/infusionsvätska, dispersionLantheus EU Limited
- United StatesDefinityLantheus Medical Imaging, Inc.
- FinlandLuminityLantheus EU Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Optison
- Iceland · Optison
- Liechtenstein · Optison
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5bc4663-aa32-4a65-be94-810b7f85ed43 GET /v1/drugs/f5bc4663-aa32-4a65-be94-810b7f85ed43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Perflutren, mikrosfærer av humant albumin",
"merkevare_id": "ID_C8190C4E-8044-499A-859B-354B916C057F",
"name_form_strength": "Optison inj væske, susp 0,19 mg/ml",
"prescription_group": "C"
}See everything about perflutren, humanalbumin-mikrosphären.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.